Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / January / Evaluating Dogs Potential Role in Cancer Screening
Oncology Screening and monitoring Research and Innovations Point of care testing

Evaluating Dogs’ Potential Role in Cancer Screening

How trained detection dogs may support early cancer screening by identifying disease-related volatile compounds

By Kathryn Wighton 01/05/2026 News 3 min read

Share

A review paper examining the use of trained medical detection dogs suggests that canine olfaction can support early cancer detection by identifying volatile organic compounds present in human biological samples.

Artificial intelligence applications have advanced diagnostic accuracy in imaging, genomics, and clinical decision support, but these systems require structured datasets and specialized infrastructure, which can limit implementation in some clinical and community settings. Trained dogs have previously identified disease-associated volatile compounds in conditions such as malaria, hypoglycemia, and COVID-19 in controlled investigations, with reported diagnostic performance varying by protocol and setting.

This paper – published in Frontiers in Medicine – offers a potential solution to Hong Kong’s cancer burden. Cancer accounted for approximately one quarter of deaths in Hong Kong in 2022, and population-based screening is currently limited to colorectal cancer for adults between 50 and 75 years of age. Screening programs for cancers such as lung, liver, breast, and pancreatic disease are not routinely implemented, contributing to a substantial proportion of diagnoses occurring at later stages.

Hong Kong’s existing use of detection dogs in customs operations demonstrates operational capacity for canine deployment. Medical biodetection, however, differs substantially from law-enforcement contexts given the variability of disease-related volatile organic compounds. Factors such as environmental odor complexity and air pollution in urban settings may further influence performance and require evaluation.

Investigations into canine detection have shown that dogs can be trained to recognize scent profiles associated with certain cancers using structured exposure to biological samples from patients with confirmed diagnoses, comparison groups with overlapping clinical features, and healthy controls. Training relies on repeated sample presentation and positive reinforcement. The approach has been described as conceptually similar to supervised machine learning, in which pattern recognition improves with the diversity and quality of training examples. Validation methods include blinded testing to measure accuracy in distinguishing target samples from nontarget samples.

The authors propose potential applications in Hong Kong that involve using detection dogs as an initial prescreening step in community or outpatient settings, followed by confirmatory imaging or laboratory testing when indicated. Considerations for feasibility include training standardization, handler expertise, environmental effects on volatile compound detection, animal welfare requirements, and operational costs.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Kathryn Wighton

Editor, Conexiant

More Articles by Kathryn Wighton

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Flexible Solutions With FlexVUE
Screening and monitoring
Flexible Solutions With FlexVUE

December 29, 2021

1 min read

Quickly customize your immune panels with Ultivue’s new innovation

What’s New in Infectious Disease? (December 2021)
Screening and monitoring
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

A Pig In a Poke
Screening and monitoring
A Pig In a Poke

October 21, 2016

1 min read

When importing livestock for food or breeding, European countries may inadvertently open their borders to superbugs as well

Sneaky Superbugs
Screening and monitoring
Sneaky Superbugs

October 21, 2016

1 min read

Norway’s strict LA-MRSA transmission measures prevent the import of almost all live pigs – but the bacteria have found a new way in

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.